The review makes it very clear that Pharmac should not be solely responsible for strategies for medicines or for rare disorders. That is the role of the ministry, and the ministry will pick that up and it will actively involve Pharmac in that because they will remain the procurement agency. They are a very good procurement agency. They've got great capability. It was interesting being at the World Health Assembly last week, with the number of countries that said, "Gee, we wish we had something like a Pharmac." So there is a lot to be pleased about and proud of with Pharmac, but improvements need to be made, as the review says, and we will ensure that those changes are made.